Star Therapeutics
@STAR_Biotech
Developing life-changing therapies for as many rare diseases as possible for the millions of patients in urgent need.
You might like
#vonWillebrandDisease is often overlooked compared to other #bleedingdisorders like hemophilia, leaving many patients without the resources & support they deserve. Listen as Nick shares his experience with a condition that was frequently misunderstood and the toll it's taken.
If you or someone you know has been diagnosed with #VonWillebrandDisease, we want to connect with you. Our VIVID (VGA039 Investigation in Von Willebrand Disease) Phase 3 clinical trial is now enrolling patients with any type of VWD aged 12-75. Learn more: star-therapeutics.com/vega-program/
A new @LEK_Consulting paper reinforces what some have long understood: VWD is the most common bleeding disorder & is deeply underserved. Innovation in VWD represents a significant growth opportunity given the patient population & low competitive intensity. lek.com/insights/hea/u…
We’re working to give a voice to patients with #vonWillebrandDisease, a #bleedingdisorder community that has too often felt unheard. Hear CEO Adam Rosenthal share insights with @BiotechTV on our Phase 1/2 VGA039 data, where all patients had substantial bleed reductions. #ASH25
𝐀𝐒𝐇 𝟐𝟎𝟐𝟓: Von Willebrand disease is the most common bleeding disorder, though many people have never heard of it. @STAR_Biotech is working on a solution that is already in phase 3. Full video: biotechtv.com/post/star-ther…
Today at #ASH25, we’re excited to announce interim Ph 1/2 data for VGA039 showing substantial bleed reductions in #vonWillebrandDisease with a once monthly subcutaneous dose. CMO Gary Patou shares insight into our commitment to innovation in #VWD. More: star-therapeutics.com/star-therapeut…
As a parent, your child’s health is paramount. For Kari, facing a #vWD diagnosis for both herself & daughter Kayla felt overwhelming. This #FamilyCaregiversMonth, they're shedding light on the genetic component of many #bleedingdisorders & sharing hope. #FamilyHistoryDay
Last weekend, we joined the @nbd_foundation at the Unite Walk to advocate for improved care. We're deeply dedicated to supporting those affected by bleeding disorders through research, funds, & advocacy. Congrats to NCBDF for rallying the community at another empowering event!
Pioneering new drugs is not an easy task, but the potential to impact patient lives is monumental. We're honored to be named a @BioSpace #BestPlaceToWork. We're proud to foster a space where collaboration thrives as we move forward with patients as our center of gravity.
Underscoring our commitment to the advancement of new therapies for those with #bleedingdisorders, we're excited to announce we'll present interim data from the Phase 1/2 multidose study of VGA039 for #vonWillebrandDisease and additional posters at #ASH25. star-therapeutics.com/star-therapeut…
For adolescent girls, #vonWillebrandDisease can lead to isolation, missed school & lost confidence—especially for those with #menorrhagia, or excessive menstrual bleeding. Hear Shanthi share her story as we work to make experiences like hers a thing of the past.
At Star, we are propelled by data with a team that champions patients. We're excited to share that CEO Adam Rosenthal has been named to @GoldmanSachs' 2025 #GSInnovators list. Adam's leadership & commitment to doing right by patients exemplify the spirit that drives us forward.
For too long, VWD patients have been unseen. Thanks to @BloodStrmMedia for sharing recent VWD updates, including the initiation of the VGA039 Ph3 trial of the 1st SC prophylactic therapy, dosed 1x/mo for all VWD types. See show notes for eligibility info. bloodstreammedia.com/bloodstream-ep…
At #EHC2025, we partnered with leading advocates & experts to challenge misconceptions in #vonWillebrandDisease and spotlight unmet needs in care. We're proud to work with organizations like @EHC_Haemophilia to elevate patient voices & drive progress in #bleedingdisorder care.
Thanks to @Nasdaq for joining us in celebrating our oversubscribed $125M Series D financing! This funding will support ongoing clinical advancement of our lead program, VGA039, to address the unmet needs of people with #bleedingdisorders, starting with #vonWillebrandDisease.
Today, we announced an oversubscribed $125M Series D financing. Funded by leading life sciences investors, this underscores the urgency of our mission: bring life-changing therapies to people with serious bleeding disorders, beginning with VGA039 in #VWD. star-therapeutics.com/star-therapeut…
At Star, patient experiences shape, inform & motivate everything we do towards providing new options to treat chronic, severe bleeding disorders, starting with #VWD. Star leaders Dr. Ben Kim & Jess Swann join @BloodStrmMedia to share more on our commitment to patients & VGA039.⬇️
VWD patients, it’s your time! Jess Swann, Patient Advocate, and Dr. Ben Kim from @STAR_Biotech breaks down the treatment gap. bit.ly/thebloodstream… Sponsor: #Takeda #bloodstreammedia #raredisease #bleedingdisorders #podcast
This week, Head of Medical Affairs Laura Guido had a special opportunity to meet with @WPABDF for an engaging dinner. Every opportunity to connect with those affected by #VWD is important to us as we work on new treatments for patients. Thank you to those who joined us!
We had a great weekend with the #hemophilia, #VWD and #bleedingdisorder communities at #13BIC! We're grateful for the opportunity to connect with industry peers & to share promising data from the Phase 1 study of VGA039 during the oral presentation session. Weekend highlights⬇️📷
We're excited to meet with the #bleedingdisorder community during @HemophiliaNC's Bleeding Disorders & VWD Community weekend! We look forward to partnering with our network to continue shaping an empowering environment for patients & caregivers. bleedingdisordersnc.org/events/2025-ul…
#VonWillebrandDisease is a lifelong condition & requires regular IV infusions 2-3 times per week in many patients. The mental toll can be just as heavy as the physical one. Listen below as Kayla shares her experience living with VWD.
United States Trends
- 1. #SmackDown 32,8 B posts
- 2. #DragRace 8.032 posts
- 3. Matt Cardona 6.696 posts
- 4. #WinterClassic 5.967 posts
- 5. Trick Williams 2.951 posts
- 6. Kit Wilson 1.567 posts
- 7. Sami 21,2 B posts
- 8. Zack Ryder 2.450 posts
- 9. Randy Orton 7.160 posts
- 10. Carmelo Hayes 1.639 posts
- 11. Johnny Gargano N/A
- 12. Rangers 29,3 B posts
- 13. Rienk Mast N/A
- 14. Jordynne Grace 2.153 posts
- 15. Jamal Murray 1.437 posts
- 16. Suggs 3.810 posts
- 17. The Miz 2.643 posts
- 18. Arizona 25,3 B posts
- 19. Mika 26,5 B posts
- 20. #RPDR18 N/A
Something went wrong.
Something went wrong.